MARIMED INC.
MARIMED INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B Convertible Preferred Stock | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Series C Convertible Preferred Stock | - | - | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
New Series B Convertible Preferred Stock | - | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 8 | 8 | 9 | 7 | 6 | 7 | 7 | 10 | 10 | 15 | 15 | 13 | |||||
Accounts Receivable Net Current | 9 | 9 | 9 | 8 | 8 | 9 | 9 | 7 | 8 | 6 | 7 | 6 | |||||
Inventory Net | 37 | 39 | 37 | 40 | 39 | 38 | 33 | 35 | 31 | 29 | 25 | 24 | |||||
Deferred Rent Receivables Net | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Notes And Loans Receivable Net Current | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Short Term Investments | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Receivables Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Current | 4 | 3 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 3 | 4 | 6 | |||||
Assets Current | 58 | 61 | 59 | 60 | 57 | 58 | 54 | 57 | 53 | 55 | 51 | 51 | |||||
Property Plant And Equipment Net | 86 | 88 | 89 | 91 | 93 | 94 | 94 | 95 | 94 | 91 | 89 | 85 | |||||
Finite Lived Intangible Assets Net | 16 | 16 | 17 | 18 | 21 | 22 | 19 | 20 | 20 | 13 | 17 | 18 | |||||
Goodwill | 24 | 24 | 24 | 23 | 20 | 19 | 16 | 16 | 16 | 16 | 12 | 12 | |||||
Notes And Loans Receivable Net Noncurrent | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | |||||
Long Term Investments | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finance Lease Right Of Use Asset | - | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | |||||
Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 13 | 13 | 12 | |||||
Assets | 197 | 201 | 203 | 206 | 204 | 208 | 207 | 213 | 209 | 201 | 196 | 191 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Secured Debt Current | - | - | - | - | - | - | - | - | - | - | - | 4 | |||||
Notes Payable Current | 3 | 3 | 3 | 2 | 3 | 5 | 5 | 4 | 4 | 1 | 1 | - | |||||
Accounts Payable Current | 13 | 15 | 15 | 11 | 11 | 14 | 13 | 13 | 12 | 10 | 9 | 8 | |||||
Accrued Liabilities Current | 10 | 10 | 10 | 9 | 7 | 8 | 4 | 6 | 5 | 5 | 4 | 5 | |||||
Contract With Customer Liability Current | 2 | 1 | 1 | 2 | - | - | 1 | - | - | - | - | - | |||||
Accrued Income Taxes Current | 32 | 30 | 27 | 28 | 25 | 25 | 22 | 17 | 16 | 16 | 14 | 14 | |||||
Operating Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Finance Lease Liability Current | - | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | |||||
Liabilities Current | 64 | 64 | 59 | 57 | 51 | 55 | 50 | 45 | 41 | 35 | 31 | 35 | |||||
Secured Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 19 | |||||
Operating Lease Liability Noncurrent | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | |||||
Finance Lease Liability Noncurrent | - | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | |||||
Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 147 | 148 | 138 | 137 | 131 | 134 | 129 | 126 | 121 | 114 | 107 | 92 | |||||
Temporary Equity | |||||||||||||||||
Temporary Equity Carrying Amount Attributable To P… | 7 | 7 | 15 | 15 | 15 | 15 | 19 | 19 | 19 | 19 | 19 | 19 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 180 | 180 | 179 | 179 | 179 | 178 | 173 | 173 | 173 | 171 | 171 | 171 | |||||
Retained Earnings Accumulated Deficit | -135 | -132 | -128 | -123 | -119 | -118 | -113 | -104 | -103 | -101 | -100 | -90 | |||||
Minority Interest | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |||||
Stockholders Equity | 43 | 47 | 50 | 54 | 57 | 58 | 59 | 67 | 69 | 69 | 70 | 80 | |||||
Common Stock Shares Subscriptions | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | |||||
Liabilities And Stockholders Equity | 197 | 201 | 203 | 206 | 204 | 208 | 207 | 213 | 209 | 201 | 196 | 191 | |||||
Allowance For Doubtful Accounts Receivable | 1 | 0 | - | 0 | 0 | 0 | - | 0 | 1 | 1 | - | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | |||||
Common Stock Shares Issued | 401 | 399 | 397 | 394 | 392 | 389 | 381 | 381 | 380 | 375 | 375 | 376 | |||||
Shares Outstanding | 401 | 399 | 397 | 394 | 392 | 389 | 381 | 381 | 380 | 375 | 375 | 376 | |||||
Common Stock Shares Subscribed But Unissued | - | - | - | - | - | - | - | - | - | - | 0 | - | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.32% | -17.07% | -21.95% | - | - | - | - | - | - | - | - | - |
| 2025 | -15.15% | -29.29% | 17.17% | 58.76% | 47.42% | 62.89% | -7.22% | 1.03% | -6.19% | -12.99% | 15.58% | 1.30% |
| 2024 | -21.82% | -34.18% | -41.82% | 6.29% | -2.86% | -5.71% | -0.68% | -18.92% | -18.24% | -11.82% | -1.82% | -32.73% |
| 2023 | - | - | - | - | - | - | -6.58% | -13.79% | 5.96% | 12.34% | 13.62% | 2.13% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.92 | 0.95 | 1.00 | 1.06 | 1.12 | 1.05 | 1.07 | 1.27 | 1.30 | 1.55 | 1.67 | 1.44 | |||||
| Quick Ratio | 0.34 | 0.34 | 0.38 | 0.35 | 0.36 | 0.37 | 0.40 | 0.49 | 0.54 | 0.73 | 0.85 | 0.75 | |||||
| Working Capital | -5.32M | -2.97M | 223.00K | 3.51M | 6.19M | 2.69M | 3.50M | 12.08M | 12.40M | 19.44M | 20.57M | 15.50M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.40 | 3.18 | 2.76 | 2.51 | 2.30 | 2.32 | 2.21 | 1.89 | 1.76 | 1.65 | 1.53 | 1.15 | |||||
| Interest Coverage TTM | -0.30 | -0.23 | -0.38 | -0.00 | -0.04 | -0.05 | 0.38 | 1.02 | 1.17 | 1.36 | 1.57 | 1.87 | |||||
| Debt Ratio | 0.75 | 0.73 | 0.68 | 0.66 | 0.64 | 0.64 | 0.63 | 0.59 | 0.58 | 0.56 | 0.55 | 0.48 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.82 | 0.79 | 0.78 | 0.75 | 0.76 | 0.77 | 0.78 | 0.78 | 0.78 | 0.79 | 0.85 | 0.87 | |||||
| Days Sales Outstanding TTM | 18.99 | 21.06 | 20.39 | 17.77 | 17.97 | 18.14 | 18.45 | 15.81 | 15.50 | 12.98 | 13.95 | 16.19 | |||||
| Receivables Turnover TTM | 19.22 | 17.34 | 17.90 | 20.54 | 20.31 | 20.12 | 19.79 | 23.09 | 23.55 | 28.11 | 26.17 | 22.54 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.04 | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 | -0.03 | -0.04 | -0.05 | -0.04 | -0.04 | -0.00 | |||||
| Free Cash Flow Per Share TTM | 0.02 | 0.02 | 0.02 | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 | -0.03 | -0.03 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 35.63% | 35.98% | 36.22% | 38.13% | 38.44% | 38.83% | 39.70% | 42.75% | 43.27% | 44.04% | 44.36% | 44.26% | |||||
| Operating Profit Margin TTM | -1.45% | -1.11% | -1.76% | -0.01% | -0.17% | -0.20% | 1.65% | 4.27% | 5.56% | 7.41% | 9.68% | 10.35% | |||||
| Net Profit Margin TTM | -9.10% | -7.88% | -9.04% | -11.71% | -10.49% | -10.58% | -7.91% | -8.93% | -11.11% | -10.95% | -10.79% | -0.76% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 4.51% | 2.36% | 1.34% | -0.60% | 0.44% | 3.64% | 6.13% | 8.48% | 10.97% | 10.97% | 10.89% | 12.62% | |||||
| Net Income Growth (1Y) | -9.31% | -23.79% | 15.95% | 30.41% | -5.25% | 0.09% | -22.23% | 1,169.64% | -396.26% | -291.35% | -217.75% | -149.44% | |||||
| EPS Growth (1Y) | -11.51% | -26.64% | 12.69% | 26.41% | -7.77% | -1.83% | -25.46% | 1,144.56% | -382.01% | -274.82% | -209.42% | -144.93% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -1.88 | -2.16 | -2.54 | -3.18 | -1.64 | -2.16 | -3.53 | -4.65 | -3.96 | -5.94 | -6.23 | -146.54 | |||||
| P/B TTM | 0.65 | 0.59 | 0.73 | 1.08 | 0.47 | 0.62 | 0.75 | 0.98 | 1.00 | 1.44 | 1.43 | 2.04 | |||||
| P/S TTM | 0.17 | 0.17 | 0.23 | 0.37 | 0.17 | 0.23 | 0.28 | 0.41 | 0.44 | 0.65 | 0.67 | 1.12 | |||||
| Market Cap | 27.97M | 27.42M | 36.67M | 58.50M | 26.90M | 35.96M | 43.98M | 65.46M | 68.69M | 99.06M | 99.94M | 162.66M | |||||
| Enterprise Value | 22.95M | 26.29M | 34.39M | 58.62M | 27.81M | 37.45M | 45.77M | 64.24M | 66.57M | 88.47M | 89.36M | 174.64M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 8.01M | 6.08M | 6.53M | 1.66M | -2.22M | -3.99M | -5.18M | -5.85M | -2.15M | -4.83M | -12.22M | -10.49M | |||||
| Net Debt | -5.02M | -1.14M | -2.28M | 125.00K | 906.00K | 1.49M | 1.79M | -1.23M | -2.12M | -10.58M | -10.57M | 11.97M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
MARIMED INC. (MRMD) — SEC Financial Statements & Analysis
MARIMED INC. (MRMD) is a medicinal chemicals & botanical products company, incorporated in DE. MARIMED INC. trades on OTC as: MRMD. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MARIMED INC. reported a 4.51% year-over-year revenue growth, a Gross Profit Margin of 35.63% (TTM), a Debt-to-Equity ratio of 3.40x, a Price-to-Sales (P/S) ratio of 0.17x (TTM), a Price-to-Book (P/B) ratio of 0.65x (TTM), at a market cap of $27.97M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 4.51%
- Gross Profit Margin TTM
- 35.63%
- Debt To Equity
- 3.40x
- P/S TTM
- 0.17x
- P/B TTM
- 0.65x
- Market Cap
- $27.97M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MARIMED INC. in?
MARIMED INC. (MRMD) operates in the Medicinal Chemicals & Botanical Products industry.
What is MRMD's market cap?
MARIMED INC. (MRMD) has a market capitalization of $27.97M as of 2026-06-30.
What exchange does MRMD trade on?
MARIMED INC. (MRMD) trades on the OTC.
Where is MARIMED INC. incorporated?
MARIMED INC. is incorporated in DE.